Shanghai Changzheng Hospital
195
53
63
24
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.0%
2 terminated/withdrawn out of 195 trials
92.3%
+5.8% vs industry average
14%
28 trials in Phase 3/4
4%
1 of 24 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (195)
Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC
Role: lead
Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC
Role: lead
Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy
Role: collaborator
MTS109 in Patients With Refractory Autoimmune Diseases
Role: lead
Postoperative Neurological Recovery and Risk Factor Analysis in Patients With Paralysis Due to Spinal Metastases
Role: lead
The Effect of Radiotherapy After Separation Surgery for Spinal Metastases
Role: lead
Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding
Role: collaborator
The Chinese Familial Alzheimer's Network
Role: collaborator
China Cognition and Aging Study
Role: collaborator
Non-Dressing vs. Routine Dressing Change After Gastrointestinal Cancer Surgery
Role: collaborator
HiSCs in the Treatment of Rheumatoid Arthritis
Role: lead
AI-Powered Precision Decision-Making for Pancreatic Diseases
Role: collaborator
A Study on the Correlation Between Tear Iron Levels and the Severity of Dry Eye Disease.
Role: lead
Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer
Role: lead
Eye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated Ophthalmopathy
Role: lead
Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Role: lead
Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Role: lead
Efficacy and Safety of Rifaximin-α in Treating MASLD
Role: lead
A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Refractory Autoimmune Diseases
Role: collaborator
A Study on the Changes of Glucose Metabolism and Exocrine Function in Patients With Chronic Pancreatitis
Role: lead